Sign In
Buy AQST
$4.03
+0.100 (+2.54%)
At Close: Jun 03, 2026
Aquestive (AQST) Up as Anaphylm Pivotal Study Meets Goals
12:51pm, Monday, 18'th Mar 2024
Aquestive's (AQST) stock rises after meeting primary and secondary goals in the pivotal study of Anaphylm Sublingual Film to treat severe allergic reactions, including anaphylaxis.
Strength Seen in Aquestive Therapeutics (AQST): Can Its 16.0% Jump Turn into More Strength?
07:51am, Monday, 18'th Mar 2024
Aquestive Therapeutics (AQST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price
WARREN, N.J., March 14, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through in
Aquestive Therapeutics (AQST) Reports Q4 Loss, Tops Revenue Estimates
07:16pm, Tuesday, 05'th Mar 2024
Aquestive Therapeutics (AQST) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.23 per share a year ago.
Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
05:05pm, Tuesday, 05'th Mar 2024
WARREN, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through inn
Wall Street Bulls Look Optimistic About Aquestive Therapeutics (AQST): Should You Buy?
10:30am, Monday, 04'th Mar 2024
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Aquestive Therapeutics (AQST) Outperforms Broader Market: What You Need to Know
07:01pm, Thursday, 29'th Feb 2024
Aquestive Therapeutics (AQST) closed the most recent trading day at $3.67, moving +0.55% from the previous trading session.
Aquestive (AQST) to Report Q4 Earnings: Here's What to Expect
11:31am, Wednesday, 21'st Feb 2024
Investor focus is likely to be on Aquestive Therapeutics' (AQST) updates regarding key pipeline candidate, Anaphylm Sublingual Film, on the fourth-quarter 2023 earnings call.
WARREN, N.J., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company” or “Aquestive”), a pharmaceutical company advancing medicines to bring meaningful imp
Aquestive Therapeutics (AQST) Registers a Bigger Fall Than the Market: Important Facts to Note
07:01pm, Tuesday, 20'th Feb 2024
In the latest trading session, Aquestive Therapeutics (AQST) closed at $2.65, marking a -1.67% move from the previous day.
WARREN, N.J., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company” or “Aquestive”), a pharmaceutical company advancing medicines to bring meaningful imp
Aquestive Therapeutics (AQST) Rises Higher Than Market: Key Facts
07:01pm, Wednesday, 14'th Feb 2024
The latest trading day saw Aquestive Therapeutics (AQST) settling at $2.68, representing a +1.13% change from its previous close.
Why Aquestive Therapeutics (AQST) Outpaced the Stock Market Today
07:01pm, Thursday, 08'th Feb 2024
Aquestive Therapeutics (AQST) closed at $2.68 in the latest trading session, marking a +1.52% move from the prior day.
Aquestive Therapeutics (AQST) Stock Sinks As Market Gains: Here's Why
07:01pm, Friday, 02'nd Feb 2024
Aquestive Therapeutics (AQST) reachead $2.63 at the closing of the latest trading day, reflecting a -1.5% change compared to its last close.
Aquestive Therapeutics (AQST) Increases Despite Market Slip: Here's What You Need to Know
07:01pm, Friday, 26'th Jan 2024
Aquestive Therapeutics (AQST) reachead $2.39 at the closing of the latest trading day, reflecting a +0.84% change compared to its last close.
